If you are a member of the general public and not a healthcare professional, NOVELTY study investigator or AstraZeneca Medical employee, please CLICK HERE to see information tailored to you.
We are pleased to announce that there were several NOVELTY presentations at the Association for Respiratory Technology & Physiology (ARTP) Conference, held on 5–6 May 2022, the International Society for Magnetic Resonance Imaging (ISMRM) – European Society for Magnetic Resonance in Medicine and Biology (ESMRMB) Joint Annual Meeting, held on 7–12 May 2022, the American Thoracic Society (ATS) International Conference, held on 13–18 May 2022, the Medical Imaging with Deep Learning (MIDL) Conference, held on 6–8 July 2022, and the European Respiratory Society (ERS) 2022 International Congress, held on 4–6 September 2022.
At ARTP, one digital poster and one oral presentation were presented based on findings from the ADPro sub-study.
At ISMRM-ESMRMB 2022, three digital posters were presented based on data from the ADPro sub-study, as follows:
At ATS 2022, three posters and one oral presentation were presented, as follows:
At MIDL 2022, two oral presentations for short conference proceedings papers were presented based on data from the ADPro sub-study, as follows:
At ERS 2022, three posters and two oral presentations were presented, as follows:
You are now leaving: http://aznoveltyproject.com/
By following this link you will be leaving the NOVELTY study website.
Please note that AstraZeneca does not take responsibility for the content displayed on other websites.